STAT1 is the main signal transducer for type I and II IFNs and plays a central role in the regulation of innate and adaptive immune responses. We used Stat1-deficient mice to test the role of donor Stat1 in MHC-matched minor histocompatibility antigen–mismatched (mHA-mismatched) and fully MHC-mismatched models of bone marrow transplantation. Lack of Stat1 in donor splenocytes reduced graft-versus-host disease (GVHD) in both immunogenetic disparities, leading to substantially attenuated morbidity and mortality. Donor Stat1 deficiency resulted in reduced alloantigen-induced activation and expansion of donor T cells and correlated with the expansion of CD4+CD25+Foxp3+ Tregs in vivo. This expansion of Tregs was further confirmed by studies showing that Stat1 deficiency promoted the proliferation, while inhibiting the apoptosis, of natural Tregs, and that absence of Stat1 enhanced the induction of inducible Tregs both in vitro and in vivo. Ex vivo expanded Stat1–/– Tregs were superior to wild-type Tregs in suppressing alloantigen-driven expansion of T cells in vitro and in inhibiting the development of GVHD. These observations demonstrate that Stat1 is a regulator of Tregs and that targeting Stat1 in CD4+ T cells may facilitate in vitro and in vivo expansion of Tregs for therapeutic use.
Huihui Ma, Caisheng Lu, Judith Ziegler, Ailing Liu, Antonia Sepulveda, Hideho Okada, Suzanne Lentzsch, Markus Y. Mapara
Title and authors | Publication | Year |
---|---|---|
Janus kinase inhibition in the treatment and prevention of graft-versus-host disease
De Togni E, Cole O, Abboud R |
Frontiers in immunology | 2024 |
PCSK9 in T-cell function and the immune response
Wang Y, Fang X, Liu J, Lv X, Lu K, Lu Y, Jiang Y |
Biomarker Research | 2024 |
Increased IFN-β indicates better survival in hepatocellular carcinoma treated with radiotherapy
Zhang Y, Hong W, Zheng D, Li Z, Hu Y, Chen Y, Yang P, Zeng Z, Du S |
Clinical and Experimental Immunology | 2024 |
IFN-gamma Receptor/STAT1 Signaling in Antigen Presenting Cells Differentially Regulates Endogenous and Exogenous Antigen Presentation During Induction of Graft versus Host Disease
Caisheng Lu, Huihui Ma, Liangsong Song, Hui Wang, Lily Wang, Shirong Li, Stephen Lagana, Antonia Sepulveda, Kasper Hoebe, Yong-Guang Yang, Suzanne Lentzsch, Markus Y. Mapara |
Journal of Clinical Investigation | 2023 |
JAKs and STATs from a Clinical Perspective: Loss-of-Function Mutations, Gain-of-Function Mutations, and Their Multidimensional Consequences.
Ott N, Faletti L, Heeg M, Andreani V, Grimbacher B |
Journal of Clinical Immunology | 2023 |
Dissecting the regulatory network of transcription factors in T cell phenotype/functioning during GVHD and GVT
Harris R, Karimi M |
Frontiers in immunology | 2023 |
Commensal bacteria promote type I interferon signaling to maintain immune tolerance in mice
Vasquez Ayala A, Hsu CY, Oles RE, Matsuo K, Loomis LR, Buzun E, Carrillo Terrazas M, Gerner RR, Lu HH, Kim S, Zhang Z, Park JH, Rivaud P, Thomson M, Lu LF, Min B, Chu H |
Journal of Experimental Medicine | 2023 |
STAT1 signaling protects self-reactive T cells from control by innate cells during neuroinflammation
Carlos A Arbelaez, Pushpalatha Palle, Jonathan Charaix, Estelle Bettelli |
JCI Insight | 2022 |
T Helper Cell Lineage-Defining Transcription Factors: Potent Targets for Specific GVHD Therapy?
J Campe, E Ullrich |
Frontiers in immunology | 2022 |
Forward Genetics in Apicomplexa Biology: The Host Side of the Story
Sánchez-Arcila JC, Jensen KD |
Frontiers in Cellular and Infection Microbiology | 2022 |
Setd2 supports GATA3(+)ST2(+) thymic-derived Treg cells and suppresses intestinal inflammation.
Ding Z, Cai T, Tang J, Sun H, Qi X, Zhang Y, Ji Y, Yuan L, Chang H, Ma Y, Zhou H, Li L, Sheng H, Qiu J |
Nature Communications | 2022 |
S100A9 upregulated by IFNGR signaling blockade functions as a novel GVHD suppressor without compromising GVL in mice
Kim S, Lim S, Kim B, Ritchey J, Vij K, Prior J, Marsala L, Stoner A, Gao F, Achilefu S, Cooper ML, DiPersio JF, Choi J |
Blood | 2022 |
GVHD Pathogenesis, Prevention and Treatment: Lessons From Humanized Mouse Transplant Models
NJ Hess, ME Brown, CM Capitini |
Frontiers in immunology | 2021 |
Repurposing a novel anti-cancer RXR agonist to attenuate murine acute GVHD and maintain graft-versus-leukemia responses
G Thangavelu, C Wang, M Loschi, A Saha, MJ Osborn, SN Furlan, K Aoyama, C McDonald-Hyman, EG Aguilar, AS Janesick, RA Chandraratna, Y Refaeli, A Panoskaltsis-Mortari, KP MacDonald, GR Hill, R Zeiser, I Maillard, JS Serody, WJ Murphy, DH Munn, B Blumberg, C Brown, V Kuchroo, LS Kean, KL Hippen, RJ Noelle, BR Blazar |
Blood | 2021 |
Janus Kinase Inhibitors and Cell Therapy
A Assal, MY Mapara |
Frontiers in immunology | 2021 |
Translational Clinical Strategies for the Prevention of Gastrointestinal Tract Graft Versus Host Disease
A Rayasam, WR Drobyski |
Frontiers in immunology | 2021 |
Computational Prediction of Biomarkers, Pathways, and New Target Drugs in the Pathogenesis of Immune-Based Diseases Regarding Kidney Transplantation Rejection.
Alfaro R, Martínez-Banaclocha H, Llorente S, Jimenez-Coll V, Galián JA, Botella C, Moya-Quiles MR, Parrado A, Muro-Perez M, Minguela A, Legaz I, Muro M |
Frontiers in immunology | 2021 |
PRMT5 regulates T cell interferon response and is a target for acute graft-versus-host disease.
Katiri Snyder, Nina C. Zitzer, Yandi Gao, Hannah K. Choe, Natalie E. Sell, Lotus Neidemire-Colley, Anora Ignaci, Charuta Kale, Raymond D. Devine, Maria G. Abad, Maciej Pietrzak, Min Wang, Hong Lin, Yang W. Zhang, Gregory K. Behbehani, Jane E. Jackman, Ramiro Garzon, Kris Vaddi, Robert A. Baiocchi, Parvathi Ranganathan |
JCI Insight | 2020 |
Human Regulatory T Cells From Umbilical Cord Blood Display Increased Repertoire Diversity and Lineage Stability Relative to Adult Peripheral Blood
K Motwani, LD Peters, WH Vliegen, AG El-sayed, HR Seay, MC Lopez, HV Baker, AL Posgai, MA Brusko, DJ Perry, R Bacher, J Larkin, MJ Haller, TM Brusko |
Frontiers in immunology | 2020 |
STAT1 signaling shields T cells from NK cell-mediated cytotoxicity
YH Kang, A Biswas, M Field, SB Snapper |
Nature Communications | 2019 |
Baricitinib-induced blockade of interferon gamma receptor and interleukin-6 receptor for the prevention and treatment of graft-versus-host disease
J Choi, ML Cooper, K Staser, K Ashami, KR Vij, B Wang, L Marsala, J Niswonger, J Ritchey, B Alahmari, S Achilefu, I Tsunoda, MA Schroeder, JF DiPersio |
Leukemia | 2018 |
Resistance to Radiotherapy and PD-L1 Blockade Is Mediated by TIM-3 Upregulation and Regulatory T-Cell Infiltration
A Oweida, MK Hararah, A Phan, D Binder, S Bhatia, S Lennon, S Bukkapatnam, BV Court, N Uyanga, L Darragh, HM Kim, D Raben, AC Tan, L Heasley, E Clambey, R Nemenoff, SD Karam |
Clinical cancer research | 2018 |
Tbet is a critical modulator of FoxP3 expression in autoimmune graft- versus -host disease
S Amarnath, A Laurence, N Zhu, R Cunha, MA Eckhaus, S Taylor, JE Foley, M Ghosh, TC Felizardo, DH Fowler |
Haematologica | 2017 |
Frontline Science: Aspirin-triggered resolvin D1 controls herpes simplex virus-induced corneal immunopathology
NK Rajasagi, S Bhela, SK Varanasi, BT Rouse |
Journal of leukocyte biology | 2017 |
Therapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic Strategies
N Villa, M Rahman, G McFadden, C Cogle |
Viruses | 2016 |
T-bet Promotes Acute Graft-versus-Host Disease by Regulating Recipient Hematopoietic Cells in Mice
J Fu, Y Wu, H Nguyen, J Heinrichs, S Schutt, Y Liu, C Liu, J Jin, C Anasetti, XZ Yu |
Journal of immunology (Baltimore, Md. : 1950) | 2016 |
STAT1-mediated translational control in tumor suppression and antitumor therapies
S Wang, AE Koromilas |
Molecular & Cellular Oncology | 2015 |
Role of Signal Transducer and Activator of Transcription 1 in Murine Allergen–Induced Airway Remodeling and Exacerbation by Carbon Nanotubes
EA Thompson, BC Sayers, EE Glista-Baker, KA Shipkowski, MD Ihrie, KS Duke, AJ Taylor, JC Bonner |
American journal of respiratory cell and molecular biology | 2015 |
γδ T cells restrain extrathymic development of Foxp3 + -inducible regulatory T cells via IFN-γ: Immunomodulation
A Visperas, B Shen, B Min |
European Journal of Immunology | 2014 |
The complex and central role of interferon-γ in graft-versus-host disease and graft-versus-tumor activity
H Wang, YG Yang |
Immunological Reviews | 2014 |
Increased mitochondrial apoptotic priming of human regulatory T cells after allogeneic hematopoietic stem cell transplantation
K Murase, HT Kim, OR Bascug, Y Kawano, J Ryan, K Matsuoka, MS Davids, J Koreth, VT Ho, C Cutler, P Armand, EP Alyea, BR Blazar, JH Antin, RJ Soiffer, A Letai, J Ritz |
Haematologica | 2014 |
Absence of STAT1 in donor-derived plasmacytoid dendritic cells results in increased STAT3 and attenuates murine GVHD
Christian M Capitini, Nicole M Nasholm, Christopher D Chien, Shannon M Larabee, Haiying Qin, Young K Song, Peter J Klover, Lothar Hennighausen, Javed Khan, Terry J Fry |
Blood | 2014 |
Suppressive oligodeoxynucleotides promote the generation of regulatory T cells by inhibiting STAT1 phosphorylation
C Bode, J Wang, DM Klinman |
International Immunopharmacology | 2014 |
PLZF confers effector functions to donor T cells that preserve graft-versus-tumor effects while attenuating GVHD
A Ghosh, AM Holland, Y Dogan, NL Yim, UK Rao, LF Young, ML West, NV Singer, H Lee, IK Na, JJ Tsai, RR Jenq, O Penack, AM Hanash, C Lezcano, GF Murphy, C Liu, M Sadelain, MG Sauer, D Sant'angelo, MR van Brink |
Cancer research | 2013 |
Biology of Graft-versus-Host Responses: Recent Insights
KP MacDonald, WD Shlomchik, P Reddy |
Biology of Blood and Marrow Transplantation | 2013 |
Antigen presenting cell-derived complement modulates murine graft versus host disease
Wing-hong Kwan, Daigo Hashimoto, ESTELA PAZ ARTAL, Katya Ostrow, Melanie Greter, Hugo Raedler, Edward Medof, Miriam Merad, Peter S. Heeger |
Journal of Clinical Investigation | 2012 |
Advances in graft-versus-host disease biology and therapy
BR Blazar, WJ Murphy, M Abedi |
Nature Reviews Immunology | 2012 |
Targeting the interleukin-6/Jak/stat pathway in human malignancies
P Sansone, J Bromberg |
Journal of Clinical Oncology | 2012 |
Conditional Stat1 Ablation Reveals the Importance of Interferon Signaling for Immunity to Listeria monocytogenes Infection
E Kernbauer, V Maier, D Stoiber, B Strobl, C Schneckenleithner, V Sexl, U Reichart, B Reizis, U Kalinke, A Jamieson, M Müller, T Decker |
PLoS pathogens | 2012 |
IFNγR signaling mediates alloreactive T-cell trafficking and GVHD
J Choi, ED Ziga, J Ritchey, L Collins, JL Prior, ML Cooper, D Piwnica-Worms, JF DiPersio |
Blood | 2012 |
Mice deficient in STAT1 but not STAT2 or IRF9 develop a lethal CD4+ T-cell-mediated disease following infection with lymphocytic choriomeningitis virus
MJ Hofer, W Li, P Manders, R Terry, SL Lim, NJ King, IL Campbell |
Journal of virology | 2012 |
Clinical perspectives for regulatory T cells in transplantation tolerance
KL Hippen, JL Riley, CH June, BR Blazar |
Seminars in Immunology | 2011 |